Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
05/02/2021 | 22:32 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:EIDX | Eidos Therapeutics Inc |
28/01/2021 | 12:05 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/01/2021 | 22:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/01/2021 | 15:01 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/01/2021 | 14:48 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/01/2021 | 14:47 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/01/2021 | 14:30 | GlobeNewswire Inc. | BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc. | NASDAQ:EIDX | Eidos Therapeutics Inc |
19/01/2021 | 22:01 | GlobeNewswire Inc. | Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera... | NASDAQ:EIDX | Eidos Therapeutics Inc |
13/01/2021 | 22:50 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
13/01/2021 | 22:30 | GlobeNewswire Inc. | BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger | NASDAQ:EIDX | Eidos Therapeutics Inc |
04/01/2021 | 13:30 | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr... | NASDAQ:EIDX | Eidos Therapeutics Inc |
15/12/2020 | 15:31 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
05/11/2020 | 13:30 | GlobeNewswire Inc. | BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
29/10/2020 | 21:48 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:EIDX | Eidos Therapeutics Inc |
29/10/2020 | 21:30 | GlobeNewswire Inc. | Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
05/10/2020 | 13:04 | GlobeNewswire Inc. | BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/08/2020 | 01:24 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:EIDX | Eidos Therapeutics Inc |
07/08/2020 | 22:30 | GlobeNewswire Inc. | Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors | NASDAQ:EIDX | Eidos Therapeutics Inc |
06/08/2020 | 22:30 | GlobeNewswire Inc. | Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
09/06/2020 | 22:01 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:EIDX | Eidos Therapeutics Inc |
08/05/2020 | 22:30 | GlobeNewswire Inc. | Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
24/04/2020 | 22:09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
24/04/2020 | 22:06 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
08/04/2020 | 16:31 | Edgar (US Regulatory) | Other Filing | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/02/2020 | 22:43 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
26/02/2020 | 22:30 | GlobeNewswire Inc. | Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/02/2020 | 18:58 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
17/11/2019 | 00:58 | GlobeNewswire Inc. | CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and ... | NASDAQ:EIDX | Eidos Therapeutics Inc |
16/11/2019 | 23:30 | GlobeNewswire Inc. | BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilizatio... | NASDAQ:EIDX | Eidos Therapeutics Inc |
31/10/2019 | 21:30 | GlobeNewswire Inc. | Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |